1963 | Cook
Cook Medical founder Bill Cook meets Dr. Charles Dotter at a Radiology Society of North America conference, sparking the beginning of a new era of minimally invasive medicine.
1964 | Dotter
Dr. Dotter is the first to perform peripheral angioplasty using a Cook wire guide and coaxial catheter system. This leads to his early work in vascular stenting.
1984 | Gianturco
Dr. Cesare Gianturco works with Cook R&D head Tom Osborne to invent the first self-expanding Z stent, the platform on which most stent grafts are based today.
1990 | Parodi
Dr. Juan Parodi combines surgical graft material and a balloon-expandable stent to perform the first AAA endovascular repair, in Buenos Aires, Argentina.
1991 | Chuter
Dr. Timothy Chuter develops the first unibody, bifurcated aortic graft. Dr. Michael Lawrence-Brown and David Hartley collaborate with Dr. Chuter to incorporate his design.
1992 | Parodi
Dr. Parodi presents at the International Endovascular Symposium (IES). Dr. Lawrence-Brown is inspired and works with Hartley to build a prototype of a modular endovascular design.
Mid-1990s | Ivancev
Dr. Krassi Ivancev plays a major role in the advancement of endovascular devices by teaching, including by training Drs. Roy Greenberg and Chuter.
1994 | Lawrence-Brown
Dr. Lawrence-Brown and Hartley develop the original preloaded graft.
1997 | Anderson
Drs. John Anderson, Tom Browne and Lawrence-Brown, along with Hartley, work with Cook Australia’s research team to develop the first fenestrated endovascular graft.
1997 | Hartley
Radiographer David Hartley and Lawrence-Brown design the first delivery system to use trigger wires for controlled deployment, the basic design which is still used in the Zenith introduction system.
1998 | Stelter
Prof. Wolf Stelter successfully implants the first fenestrated device in Europe. A few months prior, Dr. Anderson performs the first successful fenestrated endovascular aneurysm repair with a Cook device in Adelaide, Australia.
Early 2000s | Greenberg
Drs. Roy Greenberg and Chuter spearhead the development of branched grafts to treat more extensive aortic disease, including thoracoabdominal and aortic arch aneurysms.